Skip Navigation Links.

Glaxosmithkline Pharma Ltd


BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 
Market Cap: [Rs.Cr.] 16,862 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Multinational

 Discuss this stock

MF Investments

Scheme NameInv DateAmount
Invested
(Cr.)		% Net
Assets		Total NAV
[Cr.]
Franklin India Bluechip Fund - (G) 30-Apr-12 61.56 1.3 4,569.13
Franklin India Prima Plus - (G) 30-Apr-12 17.30 1.0 1,818.00
Principal Personal Tax saver Fund - (G) 30-Apr-12 8.25 1.8 454.42
Franklin India Taxshield - (G) 30-Apr-12 7.58 0.9 839.01
Principal Large Cap Fund (G) 30-Apr-12 6.99 1.8 396.50
Tata Dividend Yield Fund (G) 30-Apr-12 3.23 1.1 298.18
GS Junior BeES 30-Apr-12 2.65 3.0 87.83
ING Dividend Yield Fund (G) 30-Apr-12 2.39 2.6 92.44
Principal SMART Equity Fund (G) 30-Apr-12 2.15 1.5 145.93
Principal Dividend Yield Fund (G) 30-Apr-12 0.96 0.9 105.10
FT India Balanced Fund - (G) 30-Apr-12 0.82 0.4 216.40
ING Multi Manager Equity Fund - Opt A (G) 30-Apr-12 0.67 1.6 42.56
Templeton India Pension Plan - (G) 30-Apr-12 0.47 0.2 220.98
FT FTF - Series XII - 5Yrs - Plan C (G) 30-Apr-12 0.45 0.2 281.10
FT FTF - Series XII - 3Yrs - Plan A (G) 30-Apr-12 0.39 0.1 357.06
FT FTF - Series XIII - 3Yrs - Plan A (G) 30-Apr-12 0.37 0.1 328.28
FT India Monthly Income Plan - (G) 30-Apr-12 0.34 0.1 306.46
FT FTF - Series XII - 3Yrs - Plan B (G) 30-Apr-12 0.34 0.1 325.37
Tata Retirement Savings Fund - Progressive.. 30-Apr-12 0.27 2.4 11.46
Tata Retirement Savings Fund - Moderate (G) 30-Apr-12 0.13 2.4 5.57
FT FTF - Series XIV - 3Yrs - Plan B (G) 30-Apr-12 0.13 0.1 110.18
FT FTF - Series XV - 3Yrs (G) 30-Apr-12 0.11 0.1 91.46
FT FTF - Series IX - 5Yrs - Plan B (G) 30-Apr-12 0.10 0.2 61.14
FT FTF - Series XIV - 3Yrs - Plan A (G) 30-Apr-12 0.08 0.1 69.63
FT FTF - Series XVI - 3Yrs (G) 30-Apr-12 0.06 0.1 47.74
FT FTF - Series X - 5Yrs - Plan C (G) 30-Apr-12 0.04 0.2 24.77
ING Balanced Fund (G) 30-Apr-12 0.04 0.8 5.15
Templeton India Children's Asset - Gift Pl.. 30-Apr-12 0.03 0.4 7.26
FT FTF - Series X - 5Yrs - Plan D (G) 30-Apr-12 0.02 0.2 8.33
Tata Retirement Savings Fund - Conservativ.. 30-Apr-12 0.01 0.5 2.02
Templeton India Children's Asset - Educati.. 30-Apr-12 0.00 0.1 1.62
Reliance Vision Fund - (G) 30-Apr-12 0.00 4.7 0.00
SBI BlueChip Fund (G) 30-Apr-12 0.00 0.5 0.00
BNP Paribas Tax Advantage Plan (ELSS) (G) 30-Apr-12 0.00 0.9 0.00
Edelweiss D.G.E. Top 100 Fund - Plan A (G) 30-Apr-12 0.00 0.7 0.00
Birla Sun Life Tax Relief '96 (D) 30-Apr-12 0.00 1.1 0.00
ICICI Pru Nifty Junior Index Fund (G) 30-Apr-12 0.00 2.7 0.00
Birla Sun Life Tax Plan (D) 30-Apr-12 0.00 1.1 0.00
Birla Sun Life Dividend Yield Plus (G) 30-Apr-12 0.00 1.2 0.00
Birla Sun Life MIP II - Savings 5 (G) 30-Apr-12 0.00 0.2 0.00
BNP Paribas Equity Fund (G) 30-Apr-12 0.00 1.7 0.00
UTI-Dividend Yield Fund (G) 30-Apr-12 0.00 2.9 0.00
Birla Sun Life MNC Fund - B (G) 30-Apr-12 0.00 3.1 0.00
Reliance Top 200 Fund (G) 30-Apr-12 0.00 1.8 0.00
Edelweiss Absolute Return Fund (G) 30-Apr-12 0.00 0.6 0.00
UTI-Equity Tax Savings Plan (D) 30-Apr-12 0.00 1.3 0.00
UTI-Mastershare (D) 30-Apr-12 0.00 1.1 0.00
UTI-MNC Fund (D) 30-Apr-12 0.00 5.3 0.00
Edelweiss ELSS Fund (G) 30-Apr-12 0.00 1.5 0.00
IDBI Nifty Junior Index Fund (G) 30-Apr-12 0.00 3.0 0.00
UTI-Long Term Advantage Fund - Sr.II (G) 30-Apr-12 0.00 1.2 0.00
Birla Sun Life Buy India Fund (G) 30-Apr-12 0.00 4.4 0.00
Edelweiss Select Midcap Fund (G) 30-Apr-12 0.00 1.0 0.00
UTI-Pharma & Healthcare Fund (D) 30-Apr-12 0.00 7.0 0.00
Edelweiss Equity Enhancer Fund - Plan A (G) 30-Apr-12 0.00 1.0 0.00
UTI-Top 100 Fund (D) 30-Apr-12 0.00 1.3 0.00
Reliance Pharma Fund (Bonus) 30-Apr-12 0.00 5.0 0.00
UTI-Long Term Advantage Fund (G) 30-Apr-12 0.00 2.0 0.00
Reliance Tax Saver (ELSS) Fund - (G) 30-Apr-12 0.00 3.0 0.00
BNP Paribas Dividend Yield Fund (G) 30-Apr-12 0.00 1.7 0.00

Peer Comparison

Company Market Cap
(Rs. in Cr.) 		P/E (TTM)
(x) 		P/BV (TTM)
(x) 		EV/EBIDTA
(x) 		ROE
(%) 		ROCE
(%) 		D/E
(x)
Glaxosmit Pharma 16,861.65 26.69 8.78 23.27 30.7 47.7 0.00
Sanofi India 4,783.79 26.47 4.33 16.19 18.2 27.0 0.00
Astrazeneca Phar 4,697.00 237.52 24.81 27.64 31.7 49.8 0.00
Pfizer 3,488.45 18.87 2.67 8.63 15.7 24.0 0.00
Abbott India 3,133.74 26.67 5.76 14.58 28.3 42.4 0.00
Novartis India 2,355.93 15.50 2.88 8.97 22.6 33.8 0.00
Wyeth 1,980.28 13.69 4.05 6.89 37.4 53.1 0.01
Merck 960.73 18.09 2.34 8.45 16.8 25.3 0.00
Fulford (India) 253.50 0.00 1.69 12.29 1.2 1.9 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

D S Parekh , Chairman 

V Thyagarajan , Vice Chairman 

H B Joshipura , Managing Director 

R R Bajaaj , Director 

Company Head Office / Quarters:
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Phone : 91-022-24959595
Fax : 91-022-24959494
E-mail : ajay.a.nadkarni@gsk.com
Web : http://www.gsk-india.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
IPO
listNo IPO today
Economic Events
list Corporate Service Price (YoY)
list Hometrack Housing Survey (MoM)
Results
list No result today